ABSTRACT:
To achieve successful therapeutic results, patient compliance with prescribed treatments is essential. Compliance can be assessed in two primary ways: indirectly through the patient's self-report or directly through chemical analysis of physiological fluids. Indirect methods such as self-reporting are commonly used due to their simplicity and ease of administration. However, direct methods, including laboratory analysis of bodily fluids for the presence of drugs or their metabolites, offer a more accurate measure of adherence to prescribed therapy. Complicated drug regimens, particularly those involving multiple medications or complex dosing schedules, often result in significant challenges for patients. These challenges can include a lack of understanding of the treatment, inadequate health literacy, and the occurrence of side effects. To mitigate these challenges, strategies such as providing medication reminders, streamlining prescription programs, and offering patient education and training can be employed. These interventions help to improve patient understanding, ensure timely medication intake, and foster better adherence. Ensuring the safety of medications is also critical to patient compliance. Pharmaceutical companies must implement rigorous quality control measures to guarantee that drugs are safe and effective. Defective products, such as nasal spray actuators that break easily, medications without batch codes, or improperly packaged pills, can pose serious risks to patient health. Investigating and addressing these production defects is crucial. Potential patient hazards, such as incorrect dosages or contamination, must be identified and rectified through corrective actions. Quality control systems and patient-centered approaches in healthcare, supported by regulatory agencies such as the FDA, are necessary to safeguard drug quality and patient safety, ultimately improving therapeutic outcomes.